Your browser doesn't support javascript.
loading
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala, Hanna L M; Olson, Thomas; Clemente, Michael J; Lagström, Sonja; Ellonen, Pekka; Lundan, Tuija; Hamm, David E; Zaman, Syed Arshi Uz; Lopez Marti, Jesus M; Andersson, Emma I; Jerez, Andres; Porkka, Kimmo; Maciejewski, Jaroslaw P; Loughran, Thomas P; Mustjoki, Satu.
Afiliação
  • Rajala HL; Hematology Research Unit, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
  • Olson T; University of Virginia Cancer Center, Charlottesville, VA, USA.
  • Clemente MJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Lagström S; Institute for Molecular Medicine (FIMM), University of Helsinki, Finland.
  • Ellonen P; Institute for Molecular Medicine (FIMM), University of Helsinki, Finland.
  • Lundan T; Department of Clinical Chemistry and TYKSLAB, University of Turku and Turku University Central Hospital, Finland.
  • Hamm DE; Adaptive Biotechnologies Corp, Seattle, WA, USA.
  • Zaman SA; Institute for Molecular Medicine (FIMM), University of Helsinki, Finland.
  • Lopez Marti JM; Institute for Molecular Medicine (FIMM), University of Helsinki, Finland.
  • Andersson EI; Hematology Research Unit, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
  • Jerez A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Universidad de Murcia, IMIB-Arrixaca, Murcia, Spain.
  • Porkka K; Hematology Research Unit, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Loughran TP; University of Virginia Cancer Center, Charlottesville, VA, USA.
  • Mustjoki S; Hematology Research Unit, Department of Hematology, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland satu.mustjoki@helsinki.fi.
Haematologica ; 100(1): 91-9, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25281507
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Linfócitos T / Biomarcadores / Fator de Transcrição STAT3 / Leucemia Linfocítica Granular Grande / Evolução Clonal / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Linfócitos T / Biomarcadores / Fator de Transcrição STAT3 / Leucemia Linfocítica Granular Grande / Evolução Clonal / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Finlândia